Medtronic PLC
I · Análisis con IA
En breve
Medtronic manufactures and sells medical devices across four main areas: heart devices like pacemakers and heart valves, neuroscience products including spinal implants and brain stimulation systems, surgical tools including robotic-assisted surgery platforms, and diabetes management products like insulin pumps and glucose monitors [Company Overview]. The company serves hospitals, physicians, and patients in over 150 countries worldwide.
Medtronic is a major medical device company that makes cardiac devices, spinal implants, surgical tools, and diabetes management systems. The company faces moderate financial health concerns with slowing growth and operational inefficiencies [Yahoo Finance], but it maintains a 48-year dividend growth streak and is investing in AI-powered surgical robotics [Yahoo Finance]. Recent news highlights leadership changes in key divisions and positive momentum in new therapy development [Simply Wall St, Yahoo Finance].
Medtronic shows moderate financial concerns with slow growth and modest returns despite strong cash flow generation.
Puntuación Sentinellis
5.3/10
Moderate concerns
Capitalización bursátil
$100.9B
Ingresos (12 meses)
$33.5B
II · Noticias recientes
Qué movió el precio
6 stories · ranked by relevance
- macro2026-05-18
Mental Health Matters at Medtronic. Explore Our Employee Benefits
Yahoo Finance
- macro2026-05-19
Medtronic Neuroscience Appointment Puts Focus On Execution And Growth Risks
Simply Wall St
- macro2026-05-18
Medtronic (MDT) Advances While Market Declines: Some Information for Investors
Yahoo Finance
- macro2026-05-18
Middle East and Africa Wearable Injectors Market Trends and Forecast Report 2026-2035 Featuring Amgen, BD, Biocon, Gerresheimer, Insulet, J&J, Medtronic, Roche, West Pharmaceutical, Ypsomed
Yahoo Finance
- macro2026-05-17
A Once-in-a-Decade Opportunity: 1 Stock to Buy Hand Over Fist and Hold for Years
Yahoo Finance
- macro2026-05-14
Should Medtronic’s AVIM Hypertension Trial Shift Require Action From Medtronic (MDT) Investors?
Yahoo Finance
Premium · gratis con cualquier cuenta
Revenue growth of only 3.6% year-over-year is significantly slower than historical medtech sector averages, suggesting Medtronic may be losing competitive ground [Yahoo Finance]
Riesgos
5
Oportunidades
6
Señales de alerta
3
Dirección
10
23 hallazgos más en el informe completo — gratis con cualquier cuenta.
Desbloquea el análisis completo de Medtronic PLC
Crea una cuenta gratuita para acceder al informe completo generado con IA, con fuentes citadas en el texto.
- 5 riesgos, 6 oportunidades y 3 señales de alerta — cada uno con su fuente
- Más de 100 métricas financieras con gráficos y comparativas
- Resúmenes completos de noticias con enlaces a las fuentes
- Equipo directivo y remuneración
- Exportación a PDF para leer sin conexión
III · Empresas similares
También te puede interesar
Same sector · Healthcare or comparable health
¿La añades a tu lista?